Previous close | 0.2700 |
Open | 0.2700 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 20.00 |
Expiry date | 2024-07-19 |
Day's range | 0.2700 - 0.2700 |
Contract range | N/A |
Volume | |
Open interest | 313 |
Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Goldman Sachs 45th Annual Global Healthcare Conference, June 11-12, 2024. Jeff Simmons, President and CEO, will participate in a fireside chat on Tuesday, June 11 at 2:40 p.m. ET.
Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Food and Drug Administration (FDA) has completed its comprehensive, multi-year review of Bovaer® (3-NOP), a first-in-class methane-reducing feed ingredient, and determined the product meets safety and efficacy requirements for use in lactating dairy cattle.
On May 21, 2024, Director William Doyle purchased 15,000 shares of Elanco Animal Health Inc (NYSE:ELAN) at a price of $16.98 per share, as reported in the SEC Filing.